CXCL5



CXCL5

A1AA1P2PP2F3FF3S4SS4A5AA5M6MM6V7VV7A8AA8T9TT9E10EE10L11LL11R12RR12C13CC13V14VV14C15CC15L16LL16T17TT17L18LL18A19AA19P20PP20R21RR21I22II22N23NN23P24PP24K25KK25M26MM26I27II27A28AA28N29NN29L30LL30E31EE31V32VV32I33II33P34PP34A35AA35G36GG36P37PP37H38HH38C39CC39P40PP40K41KK41V42VV42E43EE43V44VV44I45II45A46AA46K47KK47... and 46 more residue(s)...... and 46 more residue(s)

SMILES None
InChIKey None
Sequence APFSAMVATELRCVCLTLAPRINPKMIANLEVIPAGPHCPKVEVIAKLKNQKDNVCLDPQAPLIKKVIQKILGSENKKTKRNALALVRSASTQ

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CXCL5

A1AA1P2PP2F3FF3S4SS4A5AA5M6MM6V7VV7A8AA8T9TT9E10EE10L11LL11R12RR12C13CC13V14VV14C15CC15L16LL16T17TT17L18LL18A19AA19P20PP20R21RR21I22II22N23NN23P24PP24K25KK25M26MM26I27II27A28AA28N29NN29L30LL30E31EE31V32VV32I33II33P34PP34A35AA35G36GG36P37PP37H38HH38C39CC39P40PP40K41KK41V42VV42E43EE43V44VV44I45II45A46AA46K47KK47... and 46 more residue(s)...... and 46 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.